Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
195.49
+4.53 (2.37%)
At close: Nov 25, 2025, 4:00 PM EST
195.49
0.00 (0.00%)
After-hours: Nov 25, 2025, 6:30 PM EST
BDX Revenue
In the fiscal year ending September 30, 2025, Becton, Dickinson and Company had annual revenue of $21.84B with 8.24% growth. Becton, Dickinson and Company had revenue of $5.89B in the quarter ending September 30, 2025, with 8.33% growth.
Revenue (ttm)
$21.84B
Revenue Growth
+8.24%
P/S Ratio
2.57
Revenue / Employee
$295,135
Employees
74,000
Market Cap
56.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 21.84B | 1.66B | 8.24% |
| Sep 30, 2024 | 20.18B | 806.00M | 4.16% |
| Sep 30, 2023 | 19.37B | 502.00M | 2.66% |
| Sep 30, 2022 | 18.87B | -261.00M | -1.36% |
| Sep 30, 2021 | 19.13B | 3.06B | 19.02% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BDX News
- 1 day ago - BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety - PRNewsWire
- 8 days ago - BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors - PRNewsWire
- 8 days ago - BD Onclarity™ HPV Assay for BD COR™ and BD Viper™ LT Systems Receive WHO Prequalification - PRNewsWire
- 12 days ago - Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH - PRNewsWire
- 13 days ago - BD Expands PureWick™ Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go - PRNewsWire
- 19 days ago - Becton, Dickinson and Company (BDX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal - Benzinga
- 19 days ago - Becton sees 2026 profit slightly above estimates on strong demand for drug delivery devices - Reuters